Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts.
Walgenbach
K J
KJ
Department of Surgery, University of Pittsburgh, Pennsylvania, USA.
Heeckt
P F
PF
Stanson
J D
JD
Whiteside
T L
TL
Bauer
A J
AJ
D000818:Animals; D002908:Chronic Disease; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000494:pharmacology; D015847:Interleukin-4 / Q000032:analysis*; D007413:Intestinal Mucosa / Q000276:immunology / Q000473:pathology / Q000637:transplantation*; D007422:Intestines / Q000276:immunology / Q000473:pathology / Q000637:transplantation*; D008407:Mast Cells / Q000276:immunology / Q000473:pathology*; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000494:pharmacology; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology; D014185:Transplantation, Isogeneic / Q000276:immunology* / Q000473:pathology
D007166:Immunosuppressive Agents; D015847:Interleukin-4; D016559:Tacrolimus